Dr. Przespolewski is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300
Education & Training
University at BuffaloFellowship, Hematology and Medical Oncology, 2014 - 2017- University at BuffaloResidency, Internal Medicine, 2011 - 2014
Lake Erie College of Osteopathic MedicineClass of 2011
Certifications & Licensure
NY State License 2014 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old Start of enrollment: 2021 Jul 29
Publications & Presentations
PubMed
- Optimal therapeutic strategies in relapsed/refractory AML with prior exposure to venetoclax-based therapy.Sawyer Bawek, Matthew Burwinkel, Prutha Patel, Katy Wang, Kristopher Attwood
Leukemia Research. 2025-03-01 - Significance of cycle 1 bone marrow biopsy in predicting outcomes and toxicities of venetoclax-based therapy for myeloid malignancies.Jeffrey Baron, Daniel Appiah, Mark G Faber, Han Yu, Tara Cronin
Leukemia & Lymphoma. 2024-12-27 - 1 citationsImmune Checkpoint Inhibitor Therapy and Associations with Clonal Hematopoiesis.Abhay Singh, Nuria Mencia Trinchant, Rahul Mishra, Kirti Arora, Smit Mehta
International Journal of Molecular Sciences. 2024-10-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
